Sandoz Gets Investor Suit Over Oriel Buyout Trimmed
A New York state judge has dismissed the bulk of claims in a shareholder suit against Sandoz Inc. for allegedly stalling development of a drug to avoid paying milestone bonuses to...To view the full article, register now.
Already a subscriber? Click here to view full article